Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | GFRA2 | O00451 | 1/20 | 0.43 |
| ▸ | GFRA3 | O60609 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.41 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14969006 | 0.83 | SLC6A4 (0.46) | IDO1SLC6A4SLC6A2SLC6A3GFRA3 | |
| SCHEMBL12017975 | 0.82 | IDO1 (0.61) | IDO1SLC6A4SLC6A2SLC6A3GFRA2 | |
| SCHEMBL8530467 | 0.82 | IDO1 (0.50) | IDO1GFRA2GFRA3FFAR1GID4 | |
| SCHEMBL1746643 | 0.82 | IDO1 (0.50) | IDO1SLC6A4SLC6A2SLC6A3GFRA2 | |
| SCHEMBL29279370 | 0.80 | SLC6A4 (0.44) | IDO1SLC6A4SLC6A2SLC6A3FFAR1 | |
| SCHEMBL1744666 | 0.78 | GFRA3 (0.53) | IDO1GFRA2GFRA3FFAR1 | |
| SCHEMBL20502292 | 0.75 | IDO1 (0.43) | IDO1SLC6A4GFRA2GFRA3FFAR1 | |
| SCHEMBL1746749 | 0.75 | IDO1 (0.49) | IDO1SLC6A4FFAR1 | |
| SCHEMBL14968921 | 0.75 | IDO1 (0.43) | IDO1SLC6A4SLC6A2SLC6A3FFAR1 | |
| SCHEMBL1746652 | 0.74 | GFRA3 (0.63) | IDO1GFRA2GFRA3FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024255856-A1 | COMPOUND FOR REGULATING TEAD ACTIVITY, PREPARATION METHOD THEREFOR, AND USE THEREOF | 赛诺哈勃药业（成都）有限公司 | 2024-12-19 | — | — | WO | disclosed |